ABSTRACT Nineteen female and sixteen male patients who have had their heart valves replaced with Lillehei-Kaster valves were investigated for haemolysis four to 18 months after operation. Investigations included serum lactic dehydrogenase, serum haptoglobins, and urine haemosiderin. Red cell survival, using autologous red cells labelled with 51Cr, was measured in 12 patients. No patient showed manifest anaemia. The serum lactic dehydrogenase levels were raised in 66 % of the mitral valve patients, 81 % of the aortic valve patients, and in all the double valve patients. The serum haptoglobins were decreased in 66 % of mitral patients, 68 % of aortic valve patients, and in 75 % of the double valve patients. All the 12 patients studied had lower than normal red cell survivals.
No correlation was found between the incidence of haemolysis and the size of the valve. In isolated mitral valve replacement 660% showed compensated haemolysis compared with 420% in BjorkShiley valves (p <0 05), 850% in Starr-Edwards valves (composite seat) (p < 0 O1), and none in frame-mounted irradiated homografts (previous study) (p<0 001).
The incidence of chronic intravascular haemolysis after prosthetic heart valve replacement depends on valve construction and haemodynamic performance. The Lillehei-Kaster valve, a free-floating pivoting disc valve with an opening angle of 800, was introduced in 1970 and has a sound haemodynamic performance.1 2 We have studied the incidence of chronic haemolysis in our patients who had their valves replaced with Lillehei-Kaster valves.
Patients and methods
Thirty-five patients with Lillehei-Kaster valves were investigated four to 18 months after operation. Fifteen patients had had mitral valve replacement, 16 The mean haemoglobin was 14-1 +086 g/dl in patients who had mitral valve replacement, 14 03 ± 0 99 g/dl in patients who had aortic replacement, and 12-82±1-16 g/dl in patients who had double valve replacement. One patient who had double valve replacement had a haemoglobin valve of 114 g/dl. The mean haematocrit valve was 0-41 ±002 in both the mitral and aortic valve replacements and 0 37±0 03 in patients who had double valve replacement.
The serum haptoglobins were either low or absent in 66% of the patients who had mitral valve replacement, in 68 % of the patients who had aortic valve replacement, and in 75 % of patients who had double valve replacement (table 1) .
The serum lactic dehydrogenase levels were raised in 10 (66%) of the mitral valve patients, 13 (81 %) of aortic valve patients, and in all (100%) the double valve patients. The mean serum LDH was 426-66±120-33, 514-06±209'67, and 513-75+ 231 20 in the patients who had mitral, aortic, and double valve replacements respectively (table 2).
Haemosiderinuria ranged from + to + + + in five of the mitral valve patients. Six patients had only a trace and four patients had no haemosi- derinuria. Of the patients with aortic valve replacement, four had haemosiderinuria ranging from + to + +. Six had only a trace and six had none. Two patients with double valve replacement had + haemosiderinuria, one had a trace, and one had none (fig 1) . Red cell survival studies were carried out on 12 patients who had isolated mitral valve replacement. All the patients studied had lower than normal red cell survival, the half-life of 51Cr ranging from 20 to 24-5 days (table 3) .
The reticulocyte count, red cell fragment count, glucose-6-phosphate dehydrogenase screening, DCT, Hams' test, and osmotic fragility were normal in all the patients.
COMPARISON OF HAEMOLYSIS CAUSED BY VALVES IN THE MITRAL POSITION
The serum LDH levels were raised in 66 % of patients with Lillehei-Kaster valves, in 42% of patients with Bjork-Shiley valves (p <0-01), in all (100%) the 
Discussion
Chronic haemolysis after prosthetic valve replacement is not uncommon.7-12 However, overt haemolysis manifesting as anaemia is rare. The haemolysis is intravascular. Trauma and fragmentation of red cells during their passage through the prosthetic valve is known to be the cause of haemolysis, though the exact mechanisms of such trauma are not yet clearly defined. Haemolysis has been observed in haemodynamically defective valves and where prosthetic surfaces remain unendothelialised. 13 Turbulence, cavitation, shear stress, reflux, and mechanical crushing effect all contribute to red cell trauma. An autoimmune mechanism has also been postulated.14 However, none of our patients showed evidence of an autoimmune mechanism. The flow characteristics of the valve and the inertness of the prosthetic material are considered to be the significant factors in the trauma to the red cells.
In this study, though no patient had clinically manifest anaemia, two-thirds of all our patients had compensated haemolysis. Lillehei15 reported normal mean serum LDH levels in his aortic and mitral patients and only a slight increase after double valve replacement. However 16 We also compared the relation of valve size to haemolysis. We have used mitral valve size 20M in four patients, 22M in six patients, and 25M in five patients. In the aortic position we have used size 14A in six patients, 16A in four patients, 18A in five patients, and 20A in one patient. There was no correlation between the size of the valve and the incidence of haemolysis.
In vitro tests have shown that at lower opening angles the Lillehei-Kaster valve was more obstructive compared with the Bjork-Shiley valve and was only superior to the latter valve at an opening angle of 750 or more.' Although the Lillehei-Kaster valve has been designed to open at an angle of 800, in vivo studies have shown that the disc opens only to 570 to 74°,1 causing larger gradients. In addition, in the Bjork-Shiley valve the disc does not overlap the ring, whereas in the Lillehei-Kaster valve it rests on a discontinuous biplanar seat which could have a greater mechanical crushing effect.
The Lillehei-Kaster valve produced inapparent haemolysis in a number of our patients, but there was chronic loss of fractional amounts of iron in the form of haemosiderinuria. However, the haemolysis was so mild and well compensated, that all patients maintained normal serum iron, haemoglobin, and haematocrit. This prosthetic valve is marginally more traumatic to the red cells than the BjorkShiley valve.
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